Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2421 of 5804
-
Exercise and diet may protect the brain during CAR-T cancer treatment
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if two non-pharmacological strategies can help reduce neurotoxicity caused by CAR-T cell therapy in adult patients with hematologic cancer, both sexes, aged 18 to 80 years. The strategies are: * A structured physical activity program. …
Phase: NA • Sponsor: Instituto de Investigacion Sanitaria INCLIVA • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New Nerve-Zapping device aims to cut opioid use after knee surgery
Symptom relief Recruiting nowMulti-center, randomized, blinded, sham-controlled study to determin the safety and efficacy of the NOVABLOC system on post-operative pain in patients undergoing TKA procedures.
Phase: NA • Sponsor: Synaptrix, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New eczema cream studied in kids and adults – could reduce steroid use?
Symptom relief Recruiting nowPierre Fabre Laboratories have developed a cream with medical device status, RV4421B-EV0407 indicated for the treatment of eczemas, including atopic eczema, contact eczema and chronic hand eczema. This product is already marketed in several countries. The objective of this clini…
Phase: NA • Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New eye drug hopes to slow inherited blindness
Disease control Recruiting nowThis study aims to gather safety data and determine the optimal dosing regimen for PYC-001 in participants with confirmed OPA1 mutation-associated ADOA. Approximately 18 participants from Australia, New Zealand, and other APAC countries are expected to be enrolled, depending on s…
Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Bone marrow stem cells injected for autism: first human safety test begins
Disease control Not yet recruitingThis clinical trial aims to evaluate the safety and preliminary efficacy of intravenous administration of human bone marrow-derived mesenchymal stem cells (hBMMSCs) in patients with autism spectrum disorder (ASD).
Phase: PHASE1 • Sponsor: Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC
-
New hope for babies with rare hormone disorder?
Disease control OngoingThe main objective for this study is to evaluate the pharmacokinetics (PK) of crinecerfont in pediatric participants 0 to \<2 years of age with congenital adrenal hyperplasia (CAH).
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a High-Tech care model help millions with diabetes?
Disease control Recruiting nowSixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinic…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
No more reading glasses? early trial tests Light-Based corneal treatment
Symptom relief Not yet recruitingAn 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.
Phase: NA • Sponsor: TECLens, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can virtual visits replace In-Person pain care for rural patients?
Symptom relief Not yet recruitingThis study aims to compare the effects of an in-person physiotherapist-led lifestyle-focused pain care intervention with a virtual multidisciplinary lifestyle-focused pain care intervention on pain impact in people with musculoskeletal conditions and lifestyle risks. Adults resi…
Phase: NA • Sponsor: University of Sydney • Aim: Symptom relief
Last updated Jun 26, 2026 17:17 UTC
-
New study to see if emicizumab protects Kids' joints from hemophilia damage
Disease control Not yet recruitingThe aim of our study is to investigate the effects of emicizumab treatment on the musculoskeletal system in children with hemophilia A.
Sponsor: Hasan Kalyoncu University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug emrusolmin tested for Long-Term safety in rare brain disease
Disease control Recruiting nowThe primary objective of the trial is to describe the long-term safety and tolerability of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the trial is to further describe the safety and tolerabil…
Phase: PHASE2 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
VR headsets could help seniors beat the blues
Symptom relief Recruiting nowThe primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive virtual reality (VR) headset to engage in behavioral activation (BA) for older adults diagnosed with major depressive disorder (MDD). The secondary aim of this stud…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug ABBV-932 aims to ease bipolar depression in 26-Week trial
Symptom relief Recruiting nowBipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. The purpose of this study is to assess how safe and effective ABBV-932 is in treating participants with depressive episodes associated with bipolar I or II disor…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Breathe easier: mindfulness meets pulmonary rehab in new COPD trial
Symptom relief Recruiting nowIndividuals living with chronic obstructive pulmonary disease (COPD) often suffer from stress and behavioral risks such as physical inactivity. In an attempt to promote healthy behaviors and overall wellbeing among this particular population, this study aims to develop and evalua…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to boost insulin sensitivity and muscle health in diabetes
Disease control OngoingThe main purpose of this study is to assess the effect of RO7204239 on insulin sensitivity versus placebo in participants with T2DM and obesity or overweight.
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill could ease rare bone disease
Disease control Recruiting nowThis is a phase 1/2a randomised, placebo controlled, double-blind study investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALE1 on healthy adult subjects and adult patients with Hypophosphatasia (HPP).
Phase: PHASE1, PHASE2 • Sponsor: Alesta Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a standard adult antifungal drug work safely in kids with blood cancer?
Disease control Recruiting nowThe goal of this observational study is to evaluate the efficacy the favorable response rate and safety of L-AmB(liposomal amphotericin B) for the treatment of br-IFD(breakthrough invasive fungal disease) in Chinese children and adolescent patients with hematological malignancies…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Ear zap may stop Post-Surgery headaches in aneurysm patients
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in reducing postoperative headache among adults undergoing stent-assisted coiling for unruptured intracranial aneurysms (UIAs). The study will includ…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New pill combo aims to fight Hard-to-Treat breast cancer
Disease control OngoingEvaluate the efficacy and safety of the SH3765 tablet combined with fulvestrant in the treatment of patients with advanced HR-positive breast cancer
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Bee product could ease kidney disease inflammation
Disease control Recruiting nowThe objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.
Phase: NA • Sponsor: Universidade Federal Fluminense • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC